Abstract:PurposeTo investigate associations between CT imaging features, RUNX3 methylation level, and survival in clear cell renal cell carcinoma (ccRCC).Materials and methodsPatients were divided into high RUNX3 methylation and low RUNX3 methylation groups according to RUNX3 methylation levels (the threshold was identified by using X-tile). The CT scanning data from 106 ccRCC patients were retrospectively analyzed. The relationship between RUNX3 methylation level and overall survivals was evaluated using the Kaplan-Meyer analysis and Cox regression analysis (univariate and multivariate). The relationship between RUNX3 methylation level and CT features was evaluated using chi-square test and logistic regression analysis (univariate and multivariate).Resultsβ value cutoff of 0.53 to distinguish high methylation (N = 44) from low methylation tumors (N = 62). Patients with lower levels of methylation had longer median overall survival (49.3 vs. 28.4) months (low vs. high, adjusted hazard ratio [HR] 4.933, 95% CI 2.054–11.852, p < 0.001). On univariate logistic regression analysis, four risk factors (margin, side, long diameter, and intratumoral vascularity) were associated with RUNX3 methylation level (all p < 0.05). Multivariate logistic regression analysis found that three risk factors (side: left vs. right, odds ratio [OR] 2.696; p = 0.024; 95% CI 1.138–6.386; margin: ill-defined vs. well-defined, OR 2.685; p = 0.038; 95% CI 1.057–6.820; and intratumoral vascularity: yes vs. no, OR 3.286; p = 0.008; 95% CI 1.367–7.898) were significant independent predictors of high methylation tumors. This model had an area under the receiver operating characteristic curve (AUC) of 0.725 (95% CI 0.623–0.827).ConclusionsHigher levels of RUNX3 methylation are associated with shorter survival in ccRCC patients. And presence of intratumoral vascularity, ill-defined margin, and left side tumor were significant independent predictors of high methylation level of RUNX3 gene.Key Points• RUNX3 methylation level is negatively associated with overall survival in ccRCC patients.• Presence of intratumoral vascularity, ill-defined margin, and left side tumor were significant independent predictors of high methylation level of RUNX3 gene.

EFFECTS OF RUNX3 ON CELL TURNOVER IN GASTRIC CANCER AND ITS PROGNOSTIC VALUE

Prognostic significance of RUNX3 expression in human melanoma.

Relationship Between RUNX3,cyclin E,P21 and Survival in Gastric Cancer Patients

Influence of Small Interfering RNA-mediated Inhibiting Human Runt-Related Transcription Factor 2 and Galectin-3 Gene on Proliferation and Apoptosis of Glioma Cell U251

Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis

PHD 3 Affects Gastric Cancer Progression by Negatively Regulating HIF 1 A

RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13

RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line.

Loss of expression rather than cytoplasmic mislocalization of RUNX3 predicts worse outcome in non-small cell lung cancer

Preliminary study of expression and modulating factors of runt-related transcription factor 3 and their methylation in human gastric cancer cell lines

RUNX3 Methylation and Expression Associated with Advanced Precancerous Gastric Lesions in a Chinese Population.

Activation of STAT3 in Human Gastric Cancer Cells Via Interleukin (Il)-6-type Cytokine Signaling Correlates with Clinical Implications

IGFBP3, a Transcriptional Target of Homeobox D10, is Correlated with the Prognosis of Gastric Cancer.

The Expression of RUNX3 in Hepatocellular Carcinoma and Its Clinical Significance

Dysregulated RUNX1 Predicts Poor Prognosis by Mediating Epithelialmesenchymal Transition in Cervical Cancer

RUNX3 in Stem Cell and Cancer Biology

RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers

[Relationship between RUNX3 expression and precancerous gastric lesions in high-risk population].

Pan-cancer landscape of the RUNX protein family reveals their potential as carcinogenic biomarkers and the mechanisms underlying their action

Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features

Measures of Cell Turnover (apoptosis and Proliferation) and Their Association with Survival in Gastric Cancer